Reports on CRC predicting ferroptosis have indicated that elevated GPX4 expression and decreased NOX1 and FACL4 expression suggest poor prognosis and poor clinical features [21] and protects cells from ferroptosis. Here, ACSL4 is linked to colorectal carcinoma.